Anika Therapeutics, Inc.
USD15.01
-0.09 (-0.60%)
CEO
Stephen D. Griffin
IPO Date
1993-05-03
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$15.27
Prev. Close
$15.10
Day Low
$14.96
Day High
$15.32
52W Low
$7.87
52W High
$16.24
Market Cap
$0.20B
Volume
0.07M
| -4.3 |
| 31 Dec 2023 | FY | 68.3% | -68.4% | -38.9% | -30.5% | 0.13 | 5.26 | -4.0 |
| 31 Dec 2022 | FY | 64.3% | -13.1% | -5.2% | -4.3% | 0.11 | 6.07 | -29.0 |
| 31 Dec 2021 | FY | 56.1% | 2.8% | 1.4% | 1.2% | 0.07 | 5.66 | 124.8 |
| 31 Dec 2020 | FY | 52.9% | -18.4% | -8.8% | -6.6% | 0.08 | 4.81 | -26.8 |
| 31 Dec 2019 | FY | 74.9% | 23.7% | 9.4% | 8.2% | 0.08 | 14.39 | 26.9 |
| 31 Dec 2018 | FY | 70.4% | 17.7% | 7.1% | 6.7% | 0.00 | 17.98 | 25.9 |
| 31 Dec 2017 | FY | 75.9% | 28.1% | 12.1% | 11.3% | 0.00 | 15.78 | 24.7 |
| 31 Dec 2016 | FY | 76.8% | 31.5% | 14.6% | 13.5% | 0.00 | 19.37 | 22.1 |
| 117.4 |
| 30 Sept 2025 | Q3 | 56.0% | -8.4% | -1.6% | -1.2% | 0.17 | 5.32 | -14.5 |
| 30 Jun 2025 | Q2 | 50.9% | -14.1% | -2.7% | -2.1% | 0.17 | 6.18 | -9.6 |
| 31 Mar 2025 | Q1 | 56.1% | -18.6% | -3.3% | -2.6% | 0.17 | 5.73 | -11.0 |
| 31 Dec 2024 | Q4 | -1749.2% | 1695.0% | -14.2% | -10.8% | 0.17 | 4.88 | -2.7 |
| 30 Sept 2024 | Q3 | 3.7% | -77.2% | -16.6% | -12.9% | 0.15 | 5.34 | -3.0 |
| 30 Jun 2024 | Q2 | 66.7% | -0.3% | -0.0% | -0.0% | 0.13 | 5.93 | -1089.7 |
| 31 Mar 2024 | Q1 | 60.8% | -11.1% | -2.2% | -1.7% | 0.14 | 5.59 | -20.9 |
| 31 Dec 2023 | Q4 | 61.3% | -146.6% | -29.7% | -23.3% | 0.13 | 5.26 | -1.3 |